Docgo earnings were $20.0M for the trailing 12 months ending Dec 31, 2024, with 185.7% growth year over year. The latest DCGO earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$3.3M, down 159.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DCGO reported annual earnings of $20.0M, with 191.5% growth.
DCGO past earnings growth
How has DCGO's earnings growth performed historically?
On DCGO's earnings call on Invalid Date, Docgo (NASDAQ: DCGO) reported Q4 2024 earnings per share (EPS) of -$0.03, up 137.5% year over year. Total DCGO earnings for the quarter were -$3.26 million. In the same quarter last year, Docgo's earnings per share (EPS) was $0.08.
As of the last Docgo earnings report, Docgo is currently profitable. Docgo's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $19.99 million, a 191.5% increase year over year.
What was DCGO's earnings growth in the past year?
As of Docgo's earnings date in Invalid Date, Docgo's earnings has grown 185.71% year over year. This is 142.38 percentage points higher than the US Medical Care Facilities industry earnings growth rate of 43.33%. DCGO earnings in the past year totalled $19.99 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.